Regulatory and academic studies to derive reference values for human health: The case of bisphenol S.


Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
03 2022
Historique:
received: 31 03 2021
revised: 14 10 2021
accepted: 16 10 2021
pubmed: 25 10 2021
medline: 1 4 2022
entrez: 24 10 2021
Statut: ppublish

Résumé

The close structural analogy of bisphenol (BP) S with BPA, a recognized endocrine-disrupting chemical and a substance of very high concern in the European Union, highlights the need to assess the extent of similarities between the two compounds and carefully scrutinize BPS potential toxicity for human health. This analysis aimed to investigate human health toxicity data regarding BPS, to find a point of departure for the derivation of human guidance values. A systematic and transparent methodology was applied to determine whether European or international reference values have been established for BPS. In the absence of such values, the scientific literature on human health effects was evaluated by focusing on human epidemiological and animal experimental studies. The results were analyzed by target organ/system: male and female reproduction, mammary gland, neurobehavior, and metabolism/obesity. Academic experimental studies were analyzed and compared to regulatory data including subchronic studies and an extended one-generation and reproduction study. In contrast to the regulatory studies, which were performed at dose levels in the mg/kg bw/day range, the academic dataset on specific target organs or systems showed adverse effects for BPS at much lower doses (0.5-10 μg/kg bw/day). A large disparity between the lowest-observed-adverse-effect levels (LOAELs) derived from regulatory and academic studies was observed for BPS, as for BPA. Toxicokinetic data on BPS from animal and human studies were also analyzed and showed a 100-fold higher oral bioavailability compared to BPA in a pig model. The similarities and differences between the two bisphenols, in particular the higher bioavailability of BPS in its active (non-conjugated) form and its potential impact on human health, are discussed. Based on the available experimental data, and for a better human protection, we propose to derive human reference values for exposure to BPS from the N(L)OAELs determined in academic studies.

Identifiants

pubmed: 34688643
pii: S0013-9351(21)01534-6
doi: 10.1016/j.envres.2021.112233
pii:
doi:

Substances chimiques

Benzhydryl Compounds 0
Endocrine Disruptors 0
Phenols 0
Sulfones 0
bis(4-hydroxyphenyl)sulfone 80-09-1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

112233

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Claire Beausoleil (C)

ANSES, Risk Assessment Department, France. Electronic address: claire.beausoleil@anses.fr.

Brigitte Le Magueresse-Battistoni (B)

Univ-Lyon, CarMeN Laboratory, INSERM U1060, INRAE U1397, Université Claude Bernard Lyon 1, France.

Catherine Viguié (C)

Toxalim, Institut National de la Recherche Agronomique et de l'Environnement (INRAE), Toulouse University, Ecole Nationale Vétérinaire de Toulouse (ENVT), Ecole d'Ingénieurs de Purpan (EIP), Université Paul Sabatier (UPS), Toulouse, France.

Sylvie Babajko (S)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.

Marie-Chantal Canivenc-Lavier (MC)

Centre des Sciences du Goût et de l'Alimentation, INRAE, Université de Bourgogne-France-Comté, Dijon, France.

Nicolas Chevalier (N)

Université Côte d'Azur, Centre Hospitalier Universitaire (CHU) de Nice, INSERM U1065, C3M, Nice, France.

Claude Emond (C)

University of Montreal, School of Public Health, DSEST, Montreal, Quebec, Canada.

René Habert (R)

Unit of Genetic Stability, Stem Cells and Radiation, Laboratory of Development of the Gonads, University Paris Diderot, Institut National de la Santé et de la Recherche Médicale (Inserm) U 967 - CEA, Fontenay-aux-Roses, France.

Nicole Picard-Hagen (N)

Toxalim, Institut National de la Recherche Agronomique et de l'Environnement (INRAE), Toulouse University, Ecole Nationale Vétérinaire de Toulouse (ENVT), Ecole d'Ingénieurs de Purpan (EIP), Université Paul Sabatier (UPS), Toulouse, France.

Sakina Mhaouty-Kodja (S)

Sorbonne Université, CNRS, INSERM, Neuroscience Paris Seine - Institut de Biologie Paris Seine, 75005, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH